Does RISANKIZUMAB-RZAA Cause Motor dysfunction? 9 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Motor dysfunction have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
9
Reports of Motor dysfunction with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
6
Hospitalizations
How Dangerous Is Motor dysfunction From RISANKIZUMAB-RZAA?
Of the 9 reports, 6 (66.7%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Motor dysfunction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Motor dysfunction?
DIMETHYL (363)
METHOTREXATE (354)
NATALIZUMAB (322)
INTERFERON BETA-1A (302)
ATORVASTATIN (279)
AMLODIPINE (278)
CARBIDOPA\LEVODOPA (270)
METFORMIN (270)
IRBESARTAN (240)
ESOMEPRAZOLE (233)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Motor dysfunction Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA